BARACLUDE (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the BARACLUDE drug offered from E.R. Squibb & Sons, L.L.C.. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | entecavir |
| SUBSTANCE NAME: | ENTECAVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2005-03-29 |
| END MARKETING DATE: | 0000-00-00 |
BARACLUDE HUMAN PRESCRIPTION DRUG Details:
| Item Description | BARACLUDE from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.05(mg/mL) |
| START MARKETING DATE: | 2005-03-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-1614_cecc647b-3bcf-454f-913e-6c629b3289b1 |
| PRODUCT NDC: | 0003-1614 |
| APPLICATION NUMBER: | NDA021798 |
Other ENTECAVIR Pharmaceutical Manufacturers / Labelers:
